2010

 

  • [July 2010] FDA approves Xeomin® (incobotulinumtoxinA) for the treatment of adults with:

    • Cervical dystonia, to decrease the severity of abnormal head position and neck pain

    • Blepharospasm who were previously treated with onabotulinumtoxinA (Botox)
  •